Latest AASLD News
PPAR Agonist Led to ‘Clinically Meaningful’ Improvement in PBC-Related Pruritus
BOSTON -- The investigational agent seladelpar improved markers of disease activity and…
Novel MASH Drug Reduces Liver Fat in Mid-Stage Trial
BOSTON -- Treatment with an investigational thyroid hormone receptor-beta (THR-β) agonist significantly…
Emergency Liver Transplant Effective for Severe Acute-on-Chronic Liver Failure
BOSTON -- Prioritizing emergency liver transplantation for patients with severe acute-on-chronic liver…
Novel Drug Makes Its Case for Pretreated Primary Biliary Cholangitis
BOSTON -- An investigational dual peroxisome proliferator-activated receptor (PPAR) agonist appeared effective…
AKI Response Tied to Improved Survival for Patients Waiting on Liver Transplant
BOSTON -- For patients with cirrhosis waitlisted for liver transplant who were…
MASLD Predicted to Increase by 23% by Middle of the Century
BOSTON -- A mathematical model predicts that the prevalence of metabolic dysfunction-associated…
